In today's world, it is not possible for any entity to work independently. We need strategic business partners to grow further where we can share the services to provide full spectrum services. We at Abiogenesis believe that everyone has their own core strength and to set the pace in clinical research and for faster clinical development, we need to create synergy by doing business collaboration. We work with the following partners to provide the services in different area of clinical development and at different geographic locations.
EP Group is a consulting agency based at the heart of the Russian Federation, Moscow. Abiogenesis and EP Group have been working together for many years and have now entered into a strategic partnership since 2015. All the studies of EP group in Asia PAC will be executed by Abiogenesis and studies of Abiogenesis which needs sites in Russian Federation, will be managed by EP Group. EP Group have been providing a full package of services to multinational pharmaceutical companies since 2008 and has accumulated an extensive experience in assisting different types of businesses to live up to all their company’s expectations. EP Group offers a wide range of services in Product Launch, Product Management, Regulatory Strategy and all kinds of Clinical Studies. EP Group has highly experienced, skilled and technically competent staff that allows them to challenge the most sophisticated issues.
Scitus Pharma Services Private Limited is an organization intending to provide services to the pharmaceutical and biopharmaceutical industries for bioavailability and bioequivalence studies. Abiogenesis and Scitus Pharma Services Private Limited have been working together for many years and have now joined the strategic partnership for supporting each other on clinical and bioavailability and bioequivalence studies. All the studies for Clinical Trials from Phase I to Phase IV will be executed by Abiogenesis and BA/BE and PK/PD part of study will be managed by Scitus Pharma Services Private Limited. The Scitus Pharma facility has an established state-of-the art IT infrastructure that is fully compliant with US FDA 21CFR11 requirements and also has pooled together scientists who have worked in reputed CROs and pharmaceutical companies in their previous assignments.